Doliver Capital Advisors »

Oncolytics Biotech shares owned by Doliver Capital Advisors

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Doliver Capital Advisors from 13F filings

Historical chart of Doliver Capital Advisors investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Doliver Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Doliver Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $85k 100k 0.85

More positions owned by Doliver Capital Advisors

Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Us Gwt (IUSG)
Tidal Trust Ii Dga Core Plus Ab (HF)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Ishares Tr Core S&p Ttl Stk (ITOT)
Eaton Corp SHS (ETN)
Ishares Tr Russell 2000 Etf (IWM)
Enterprise Products Partners (EPD)
Visa Com Cl A (V)

View all positions for Doliver Capital Advisors

Top funds holding Oncolytics Biotech

Sandbox Financial Partners
Marshall Wace
Seeds Investor
Tocqueville Asset Management
Everhart Financial Group
Doliver Capital Advisors
LPL Financial
XTX Topco
Virtu Financial
Franklin Resources
Geode Capital Management
CIBC World Markets
PFG Investments
UBS Group
Atlantic Trust

View all funds holding Oncolytics Biotech